FDA warns on mixing opioid addiction treatments, other meds

September 20, 2017 by Linda A. Johnson

The Food and Drug Administration has issued new warnings about the dangers of combining medication for opioid addiction with antidepressants and other drugs that also slow breathing and brain activity.

The FDA warns that mixing such drugs can cause difficulty breathing, coma or death and should be done with caution.

Many patients fighting opioid addiction by taking methadone or buprenorphine (byoo-preh-NOR'-feen) also take other that slow action of the central nervous system. Those include the medications Ambien and Lunesta for insomnia, Valium and Xanax for anxiety, muscle relaxers Soma and Zanaflex and Abilify, Invega, Saphris and others.

Meanwhile, the agency stressed that treating opioid addiction with medication is crucial to curbing the U.S. opioid epidemic.

Explore further: Starting opioid addiction treatment in the ED is cost-effective

Related Stories

Starting opioid addiction treatment in the ED is cost-effective

August 16, 2017
The most cost-effective treatment for people with untreated opioid addiction who visit the emergency department (ED) is buprenorphine, a medication to reduce drug cravings and withdrawal, say Yale researchers. Their study ...

Medicaid patients continue high prescription opioid use after overdose

August 22, 2017
Despite receiving medical attention for an overdose, patients in Pennsylvania Medicaid continued to have persistently high prescription opioid use, with only slight increases in use of medication-assisted treatment, according ...

Scientists reveal new insights and possible solutions for opioid epidemics using machine

September 13, 2017
Mount Sinai researchers have identified unique structural, biological and chemical insights in the way different opioid drugs activate the receptors and specific signaling pathways responsible for the drug's beneficial and ...

Long-term opioid prescription use jumps threefold over 16-year period, study suggests

September 7, 2017
A new study from the Johns Hopkins Bloomberg School of Public Health found that opioid prescription use increased significantly between 1999 and 2014, and that much of that increase stemmed from patients who'd been taking ...

Ohio sues five drugmakers over role in opioid crisis

May 31, 2017
The US state of Ohio on Wednesday sued five major producers of prescription opioid medications, accusing them of lying about the deadly risks the painkillers—at the center of a nationwide addiction crisis—posed to public ...

Treating acute pain in opioid-dependent patients: Review and recommendations

September 13, 2017
As healthcare providers see more patients with opioid abuse and dependence, they face a difficult challenge: What's the best way to manage acute pain without contributing to the patient's opioid use disorder (OUD)? A review ...

Recommended for you

Novel botulinum toxin compound relieves chronic pain

July 18, 2018
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to research by UCL, ...

FDA recalls heart medication valsartan, citing cancer concerns

July 17, 2018
The U.S. Food and Drug Administration issued a voluntary recall of several medications that contain the active ingredient valsartan, which is used to treat high blood pressure and heart failure.

Opioids given too easily to children: study

July 16, 2018
(HealthDay)—Many children are prescribed powerful opioid painkillers they don't really need, putting them and those around them at risk, a new study shows.

Study reveals opioid patients face multiple barriers to treatment

July 12, 2018
In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Report details possible conflict of interest issues for FDA advisors

July 6, 2018
Charles Piller, a contributing correspondent for the journal Science, has published a Feature piece in the journal detailing what he describes as possible conflicts of interest issues by people who serve as advisors to the ...

Opioid epidemic responses overlook gender

July 5, 2018
Yale health experts warn that current efforts to confront the growth of opioid addiction and overdose deaths must better incorporate an understanding of how women fit into this epidemic.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.